R-Pharm agrees to start production of a Chinese Beijing HPV vaccine in Russia

28 May 2021

Russian pharmaceutical company R-Pharm and Chinese biotech company Beijing Health Guard signed a local manufacturing content agreement for the production of a nine-valent vaccine for human papilloma virus (HPV) prevention in Russia, as reported by R-Pharm.